CSRG minimal important difference (MID) estimates for patient-reported outcomes stratified by subset of limited and diffuse SSc.
| Limited | Diffuse | |||||
|---|---|---|---|---|---|---|
| Patient-reported Outcome | Mean MID (SD) in “Somewhat better” Subgroup | Mean (SD) Change in “Same” Subgroup | Mean (SD) MID in “Somewhat worse” Subgroup | Mean MID (SD) in “Somewhat better” Subgroup | Mean (SD) Change in “Same” Subgroup | Mean (SD) MID in “Somewhat worse” Subgroup |
| PCS | 2.25 (6.97) (n = 24) | 0.585 (5.81) (n = 101) | –1.92 (7.27) (n = 50) | 2.24 (6.42) (n = 22) | –0.585 (7.00) (n = 65) | –0.953 (8.41) (n = 35) |
| MCS | 0.186 (5.53) (n = 24) | 1.67 (8.69) (n = 101) | –2.74 (11.27) (n = 50) | 2.61 (9.79) (n = 22) | 3.05 (9.83) (n = 65) | –2.66 (10.72) (n = 35) |
CSRG: Canadian Scleroderma Research Group; SSc: systemic sclerosis; PCS: Physical Component Summary; MCS: Mental Component Summary.